Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) EBITDA (2023 - 2025)

Historic EBITDA for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to $6.0 million.

  • Medical Group Holdings' EBITDA fell 7442.06% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.9 million, marking a year-over-year decrease of 4125.63%. This contributed to the annual value of $30.1 million for FY2024, which is 1308.77% up from last year.
  • According to the latest figures from Q3 2025, Medical Group Holdings' EBITDA is $6.0 million, which was down 7442.06% from $11.1 million recorded in Q2 2025.
  • In the past 5 years, Medical Group Holdings' EBITDA ranged from a high of $31.3 million in Q1 2025 and a low of -$11.6 million during Q4 2024
  • In the last 3 years, Medical Group Holdings' EBITDA had a median value of $8.6 million in 2024 and averaged $9.6 million.
  • Within the past 5 years, the most significant YoY rise in Medical Group Holdings' EBITDA was 232639.48% (2024), while the steepest drop was 15496.55% (2024).
  • Over the past 3 years, Medical Group Holdings' EBITDA (Quarter) stood at $21.0 million in 2023, then tumbled by 154.97% to -$11.6 million in 2024, then skyrocketed by 152.29% to $6.0 million in 2025.
  • Its EBITDA was $6.0 million in Q3 2025, compared to $11.1 million in Q2 2025 and $31.3 million in Q1 2025.